AR230266A1 - Procedimiento para obtener haluros de 2-(2-(2-(4metoxibenzoil)amino)-fenil)-etil)-1,1-metilalquil o bencilpiperidinio - Google Patents

Procedimiento para obtener haluros de 2-(2-(2-(4metoxibenzoil)amino)-fenil)-etil)-1,1-metilalquil o bencilpiperidinio

Info

Publication number
AR230266A1
AR230266A1 AR288281A AR28828182A AR230266A1 AR 230266 A1 AR230266 A1 AR 230266A1 AR 288281 A AR288281 A AR 288281A AR 28828182 A AR28828182 A AR 28828182A AR 230266 A1 AR230266 A1 AR 230266A1
Authority
AR
Argentina
Prior art keywords
benzylpiperidinum
methylalkyl
phenyl
ethyl
amino
Prior art date
Application number
AR288281A
Other languages
English (en)
Spanish (es)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Application granted granted Critical
Publication of AR230266A1 publication Critical patent/AR230266A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AR288281A 1981-01-28 1982-01-28 Procedimiento para obtener haluros de 2-(2-(2-(4metoxibenzoil)amino)-fenil)-etil)-1,1-metilalquil o bencilpiperidinio AR230266A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/229,244 US4321386A (en) 1981-01-28 1981-01-28 Quaternary piperidinium halides

Publications (1)

Publication Number Publication Date
AR230266A1 true AR230266A1 (es) 1984-03-01

Family

ID=22860396

Family Applications (1)

Application Number Title Priority Date Filing Date
AR288281A AR230266A1 (es) 1981-01-28 1982-01-28 Procedimiento para obtener haluros de 2-(2-(2-(4metoxibenzoil)amino)-fenil)-etil)-1,1-metilalquil o bencilpiperidinio

Country Status (19)

Country Link
US (1) US4321386A (nl)
JP (1) JPH0348904B2 (nl)
AR (1) AR230266A1 (nl)
AT (1) AT378183B (nl)
AU (1) AU551523B2 (nl)
BE (1) BE891938A (nl)
CA (1) CA1184917A (nl)
CH (1) CH651021A5 (nl)
DE (1) DE3223499T1 (nl)
DK (1) DK156649C (nl)
FI (1) FI65239C (nl)
GB (1) GB2100736B (nl)
GR (1) GR74720B (nl)
IE (1) IE52420B1 (nl)
IT (1) IT1147809B (nl)
NL (1) NL8220049A (nl)
SE (1) SE435057B (nl)
WO (1) WO1982002551A1 (nl)
YU (1) YU43063B (nl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG176772A1 (en) * 2009-04-09 2012-01-30 Cognition Therapeutics Inc Inhibitors of cognitive decline
ES2547730T3 (es) 2009-07-31 2015-10-08 Cognition Therapeutics, Inc. Inhibidores del deterioro cognitivo
AU2012212219B2 (en) 2011-02-02 2017-03-23 Cognition Therapeutics, Inc. Isolated compounds from turmeric oil and methods of use
AU2015210852B2 (en) 2014-01-31 2019-01-24 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
CA3061787A1 (en) 2017-05-15 2018-11-22 Cognition Therapeutics, Inc. Compositions for treating neurodegenerative diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3037910A (en) * 1958-04-18 1962-06-05 Burroughs Wellcome Co Process for treatment of hypertension
US3931195A (en) * 1971-03-03 1976-01-06 Mead Johnson & Company Substituted piperidines
US3917679A (en) * 1974-04-12 1975-11-04 Lilly Co Eli Quaternary ammonium salts of N-dialkylaminoalkyl-N-(2-indanyl)anilines

Also Published As

Publication number Publication date
IT1147809B (it) 1986-11-26
AU8148582A (en) 1982-08-16
DK156649B (da) 1989-09-18
DK429382A (da) 1982-09-27
IE52420B1 (en) 1987-10-28
IE820191L (en) 1982-07-28
SE8205535D0 (sv) 1982-09-28
SE435057B (sv) 1984-09-03
DE3223499C2 (nl) 1989-11-23
ATA900782A (de) 1984-11-15
FI822443L (fi) 1982-07-08
CA1184917A (en) 1985-04-02
CH651021A5 (de) 1985-08-30
BE891938A (fr) 1982-07-28
GB2100736A (en) 1983-01-06
YU43063B (en) 1989-02-28
FI65239B (fi) 1983-12-30
SE8205535L (sv) 1982-09-28
WO1982002551A1 (en) 1982-08-05
US4321386A (en) 1982-03-23
YU19782A (en) 1985-04-30
DE3223499T1 (de) 1983-01-13
DK156649C (da) 1990-02-05
IT8247667A0 (it) 1982-01-28
FI65239C (fi) 1984-04-10
GB2100736B (en) 1985-01-30
NL8220049A (nl) 1982-11-01
AT378183B (de) 1985-06-25
JPH0348904B2 (nl) 1991-07-25
AU551523B2 (en) 1986-05-01
JPS57502216A (nl) 1982-12-16
FI822443A0 (fi) 1982-07-08
GR74720B (nl) 1984-07-10

Similar Documents

Publication Publication Date Title
ES535945A0 (es) Procedimiento para preparar 2-(bezoil-2-sustituido)-ciclohexano-1, 3-dionas herbicidas
ES535946A0 (es) Procedimiento para preparar 2-(2-benzoil sustituido)-1, 3-ciclohexanodionas
ES523733A0 (es) Procedimiento para preparar acilanilidas.
ES515084A0 (es) Procedimiento para la obtencion de 2-arilimidazopiridinas.
ES523067A0 (es) Procedimiento para preparar 1-(2-(fenilmetilen)ciclohexil) azetidinas.
ES515786A0 (es) Procedimiento para preparar metilaminas.
ES519006A0 (es) Procedimiento para preparar 2-(2-dimetilaminoetiltio)-3-fenilquinolina.
ES537343A0 (es) Procedimiento para la obtencion de azoles 2, 4, 5-trisustituidos
ES515445A0 (es) Procedimiento para la obtencion de amino-organoaminosilosanos.
ES516842A0 (es) Procedimiento para la obtencion de benzofuranonas.
AR230266A1 (es) Procedimiento para obtener haluros de 2-(2-(2-(4metoxibenzoil)amino)-fenil)-etil)-1,1-metilalquil o bencilpiperidinio
ES518617A0 (es) Procedimiento para la obtencion de p-tercioctil-fenol.
MX6975E (es) Procedimiento para preparar s,s-dialquil-fosforoditioatos de o-alquilo
ES522324A0 (es) Procedimiento para la obtencion de 2-(4-hidroxifenoxi)-propionatos.
ES527279A0 (es) Un procedimiento para obtener 2-(2,3,5-tri-o-aril-b-d-ribofuranosil)selenazol-4-carboxilatos de alcohilo o aralcohilo
ES534947A0 (es) Procedimiento para la obtencion de 2-(1-indolinil-metil)-imidazolinas
ES510302A0 (es) Procedimiento para la preparacion de 4-(3-trifluormetilfenil)-1,2,3,6-tetrahidropiridinas.
ES517646A0 (es) Procedimiento para preparar nuevos compuestos anti-helminticos.
AR229877A1 (es) Procedimiento para preparar 1-(2-(4,5,10,11-tetrahidro-1-h-dibenzo(a,d)ciclohepten-5-il)-etil)pirro-lidina
ES518680A0 (es) Procedimiento para preparar compuestos de ferrosiloxano.
ES534092A0 (es) Procedimiento para la obtencion de 2-(n-(2-hidroxietil)-carbamoil)-3-metil-quinoxalin-1, 4-n-dioxido estabilizado
ES544201A0 (es) Procedimiento para preparar 2- (fenetil) -5- (3,4-metilen- dioxi)-x-hidroxibencil) -pirrolidina
ES517996A0 (es) Un procedimiento para preparacion de 2-(2-piridila cetil)-p-anisanilida.
ES516922A0 (es) Procedimiento para la obtencion de o-pirazol-4-il-carbamatos n-sustituidos.
ES512595A0 (es) Procedimiento para preparar 4-alquil-tiofenil-etanolaminas.